Welcome: Guest

log in

Petrodollars - Transformation of Oil Wealth into Financial Wealth

Publication Date December 2008
Publisher Frost & Sullivan
Product Type Report
Pages 104
ISBN Number not applicable
Product Code FRS00962
Buy this product or for assistance call +44 20 7060 7474

Summary

Frost & Sullivan's bottled Financial Benchmarking and Analysis (FBA) service presents a financial outlook of the trend of Petrodollar Investments and its impact on global economy. It is a comprehensive study encompassing the major oil funds of the world and analysing the pattern of investments adopted by them. The FBA focuses on flow of surplus oil revenues into the following sectors such as: Domestic Spending, Real Estate, Banking and Financial Services, Industrial, Hospitality, Tourism, Energy, Sports, Shopping Malls, etc.

Content

  • 1 Executive Summary
    • Executive Summary
      • Executive Summary
  • 2 Introduction and Methodology
    • Methodology
      • Methodology
    • Introduction
      • Introduction to Research
  • 3 Introduction to Petrodollars
    • Introduction to Petrodollars
      • Sovereign Wealth Funds - An Insight
      • Introduction to the Term Petrodollars
  • 4 Petrodollar Investments
    • Favourable Petro-economics
      • Significance of Petrodollar Investments
    • Sector-wise Asset Allocation
      • Introduction
      • Domestic Spending
      • Real Estate
      • Banking and Financial Services
      • Aerospace and Defense
      • Hospitality and Tourism
      • Industrial
      • Healthcare
      • Other International Investments
      • Asset Allocation by Value and Volume
  • 5 Pattern of Petrodollar Investments
    • Favourable Destinations
      • Investment Patterns
      • Currency Composition and Growing Focus on Emerging Markets
      • Final Thoughts
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri

Industry Events

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>